Inflammatory status in human hepatic cirrhosis

Area of Science:

• Hepatology
• Immunology
• Gastroenterology

Background:

• Liver cirrhosis results from persistent damage and chronic inflammation, leading to fibrotic scar tissue.
• The balance between tissue regeneration and fibrosis determines recovery or cirrhosis development.
• Dysregulation of immune system homeostasis drives cirrhosis progression.

Purpose of the Study:

• To review new findings on inflammatory status in human liver cirrhosis caused by Hepatitis C Virus (HCV) infection and chronic alcohol abuse.
• To identify differences in inflammatory mechanisms between HCV-induced and alcohol-induced cirrhosis for targeted interventions.
• To focus on human studies, excluding animal models.

Main Methods:

• Review of current scientific literature on human liver cirrhosis.
• Analysis of inflammatory pathways and immune system dysregulation in HCV and alcohol-induced cirrhosis.
• Comparative analysis of cellular and molecular mechanisms.

Main Results:

• HCV-related cirrhosis (HCV-C) is characterized by viral immune evasion, including inhibition of interferons and immune cell activity.
• Alcohol-induced cirrhosis involves direct hepatotoxicity from ethanol metabolites and increased intestinal permeability.
• Alcohol-induced cirrhosis exhibits a stronger pro-inflammatory response due to bacterial translocation from the gut.

Conclusions:

• Therapeutic strategies for HCV-C should focus on overcoming viral immune evasion.
• Interventions for alcohol-induced cirrhosis should target the gut-mesenteric-systemic inflammatory axis.
• Understanding distinct inflammatory profiles is crucial for effective, cause-specific cirrhosis treatment.